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Summary Peripheral B-lymphocytes of 13 patients with uveal melanoma and of 5 healthy individuals were
transformed with Epstein-Barr virus (EBV). The reactivity of these transformed cells with autologous or
allogeneic melanoma cells and lymphocytes was measured by the enzyme-linked immunosorbent assay
(ELISA). Antigens which are neither self nor common environmental antigens (i.e., plant protoplasts,
schistosome antigen and keyhole limpet haemocyanin) were used for controls. Lymphocyte reactivity with all
types of antigen was apparent both in patients with uveal melanoma and in normal controls. The response
detected by the techniques available is likely to reflect antibody multispecificity leading to mis-identification of
irrelevant antigens.
The humoral immune response to tumour antigens is diffi-
cult to investigate. Firstly, relevant specific anti-tumour
antibodies may not be detected in serum because they are
already bound to circulating tumour-associated antigens or
to anti-idiotypic antibodies. Secondly, the specific reactivity
of such anti-tumour serum antibodies with tumour-
associated antigens may be masked by the reactivity of other
antibodies with non-specific antigens expressed by the
tumour cells.
EBV infection is known to transform human lymphocytes
which have recently been exposed to relevant antigens
(Steinitz et al., 1979). This phenomenon, together with cell
fusion experiments, has been exploited to perform in vitro
studies of the anti-tumour humoral immune response in a
variety of non-ocular neoplasms (Cote et al., 1986; Hough-
ton et al., 1983; Campbell et al., 1986). Such an experimental
approach has another advantage, at least in theory: relevant
B-lymphocytes could be propagated indefinitely in vitro for
the production of human monoclonal antibodies and these
antibodies could then be used to investigate the nature of the
tumour-associated antigens that are stimulating the immune
response. This approach has not previously been applied to
the study of ocular melanomas.
In this study, the EBV transformation technique was used
to investigate the B-lymphocyte reactivity of patients with
uveal melanoma against autologous melanoma cells and
autologous normal lymphocytes. In addition, the B-
lymphocyte reactivity with allogeneic melanoma cells was
measured in patients with uveal melanoma and in healthy
individuals. The significance of the results obtained was
investigated by measuring the apparent B-lymphocyte reacti-
vity with antigens which were unlikely to have been encoun-
tered previously by the individuals being tested. These were
plant protoplasts from the tobacco plant as a cellular
control, keyhole limpet haemocyanin as a purified protein
control, and schistosome whole worm antigen as a complex
mixture of foreign protein and carbohydrate.
We report here the findings of this investigation of the
humoral immune response to uveal melanoma.
Materials and methods
Preparation and transformation of human B-lymphocytes
A single venous blood sample was obtained from 12 patients
with uveal melanoma and from 5 healthy individuals. Two
venous blood samples were taken from an additional patient
with uveal melanoma for use in a reproducibility study.
Each blood sample (10-20 ml) was added to an equal
volume of 2% foetal calf serum (FCS) in RPMI medium,
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layered over an equal volume of Ficoll-Paque, and centri-
fuged at 300g for 15 min at room temperature. The cells at
the fluid interface were harvested, washed in RPMI medium,
and counted. They were then incubated at a concentration of
107 cells ml - for 1 h with EBV obtained from the superna-
tant of the B95-8 marmoset cell line (Miller & Lipman,
1973), then washed and aliquoted at 105 cells/well in the
central 60 wells of a 96-well Costar plate. CyclosporinA,
1 ,gml-', was added to the 20% FCS medium to inhibit T-
cell activity (Shevach, 1985) so that suppression of B-cell
growth would be prevented (Bird et al., 1981). The trans-
formed lymphocytes (transformants) were fed with fresh
medium at weekly intervals. Supernatants were removed for
assay in the interval spanning 10-21 days, during which time
the cells continue to secrete large amounts of antibody.
Derivation of antigens
Relevant antigens Blocks of uveal melanoma tissue
(5 x 4 x 4mm) were excised from 15 fresh tumours which
were treated either by local surgical resection (Foulds, 1978)
or by enucleation. Using the plunger of a disposable 10ml
syringe, the tumour tissue was passed through a stainless
steel wire mesh into a 6cm petri dish containing RPMI. A
sample of the cell suspension was counted with a Neubauer
haemocytometer and the integrity of the cells was deter-
mined by examining a parallel sample by phase contrast
microscopy.
Irrelevant antigens Protoplasts were prepared from Nico-
tiana plumbaginifolia (tobacco plant) by the method of
Sidorov and Maliga (1982). Keyhole limpet haemocyanin
(KLH) was purchased from Sigma Chemicals, Poole, Dorset.
Schistosome whole adult worm antigen was prepared by
homogenisation of whole worms from Schistosoma mansonai
in phosphate buffered saline followed by centrifugation at
500g after 16h incubation at room temperature, and was a
gift from Dr Janet Jones, Department of Biochemistry,
University of Glasgow.
Enzyme-linked immunosorbent assay (ELISA)
The ELISA was similar to that described by Effros and
associates (1985). Flat-bottomed, 96-well microtitre plates
were rinsed briefly in warm distilled water. Aliquots of a cell
suspension, consisting of 104 cells/!100 ug, were dispensed to
all wells with the exception of row 1 of the plate. The plates
were incubated in air at 37°C until they were completely dry
and then wrapped in clingfilm and stored at 4°C until use.
KLH and schistosome whole worm antigen were applied to
the wells at concentrations of lOjug 1OO ud l and
2 ,g 100pl 1 respectively and incubated for 16 h at 4°C. The
plates were then washed with PBS containing 0.05% Tween
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and incubated with 100 ,l transformant for 16 h at 4°C,
After a further wash, the wells were incubated with 100,l
horseradish peroxidase-labelled rabbit anti-human IgG
(H +L) (Dako) for 30 min at room temperature. This reagent
detected IgM as well as antibodies by reaction with the
constant region of the light chains. The wells were washed
again and incubated with 100 pi orthophenylene diamine
(0.4mgml-1 in 0.01% H202). The reaction was arrested by
the addition of 50,pl 4N H2SO4 and the light absorbance
read at 492nm using a Titretek Multiskan spectrophoto-
meter. Six control wells on each plate contained 20% FCS
instead of the transformant supernatant. Results greater than
three standard deviations of the mean of the 6 control
readings were considered to be positive.
Reproducibility study
A sample of venous blood was divided into two aliquots
from which two preparations of lymphocytes were extracted.
These were EBV-transformed separately and then assayed
simultaneously on two different allogeneic uveal melanomas.
One day after the first two transformations, EBV-
transformation was performed on lymphocytes from a
second blood sample from the same patient, and assayed
against cells from the same two allogeneic uveal melanomas.
Reactivity with autologous melanoma cells and lymphocytes
The reaction of the peripheral B-cells of 5 patients with
uveal melanoma was simultaneously tested against autolo-
gous tumour and B-lymphocytic cells.
Reactivity with allogeneic melanoma cells and lymphocytes
The reactions of peripheral B-lymphocytes of 5 patients with
uveal melanoma and 5 healthy individuals were tested
against allogeneic melanoma cells.
Reactivity with irrelevant antigens
The reactivities of peripheral B-lymphocytes of 2 patients
with uveal melanoma and one healthy individual were tested
against plant protoplasts, keyhole limpet haemocyanin and
schistosome whole worm antigen. In each case, uveal mela-
noma was used as a positive control.
Results
Reproducibility study
The reactivity of B-lymphocytes of patient JB with mela-
noma cells of patient MT was stronger than the reactivity
with the melanoma cells of patient JS (Figure 1). The
two lymphocyte preparations derived from the same blood
sample showed good repeatability, that is, to within 10%.
The lymphocyte preparation derived from the second blood
sample showed good repeatability when tested against
patient JS (i.e. 0-3%) and moderate repeatability when
tested against patient MT (i.e. 13-18%).
Reactivity with autologous melanoma cells and lymphocytes
Three patients apparently reacted more strongly with the
melanoma cells whereas 2 patients reacted more strongly
with the lymphocytes (Figure 2).
Reactivity ofpatients and healthy individuals with
allogeneic melanoma cells
The reactivity of the healthy individuals with the tumour
cells was almost as strong as that seen in the patients with
uveal melanoma (Figure 3).
Reactivity with irrelevant antigens
Figure 4 shows the reactivity of 3 individuals with irrelevant
antigens consisting of plant protoplasts, keyhole limpet
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Figure I Reproducibility of measurement of ELISA reactivity
of EBV transformed B-lymphocytes with allogeneic uveal mela-
noma cells. Two samples of lymphocytes prepared individually
from the same venous blood sample of a patient (JB) with uveal
melanoma were transformed separately (1 and 2). A third EBV
transformation was performed on lymphocytes obtained one day
later from the same patient (3). The reactivity of the three
preparations of transformed B-lymphocytes with cells from two
allogeneic uveal melanomas was measured by ELISA (JS and
MT respectively). The histogram shows the percentage of trans-
formants with optical density readings greater than the
mean+3 s.d. of 6 controls.
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Figure 2 ELISA reactivity of EBV transformed B-lymphocytes
of patients with uveal melanoma with autologous tumour cells
and lymphocytes. The results are obtained and displayed as in
Figure 1. Three patients apparently reacted more strongly with
the melanoma cells whereas two patients reacted more strongly
with the lymphocytes.
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Figure 3 ELISA reactivity with allogeneic uveal melanoma cells
of EBV transformed B-lymphocytes of patients with uveal mela-
noma and healthy individuals. The results are obtained and
displayed as in Figure 1. The reactivity of the healthy individuals
with the tumour cells was almost as strong as that seen in the
patients with uveal melanoma.
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Figure 4 ELISA reactivity of EBV transformed B-lymphocytes of two patients with uveal melanoma (GL and ML) and one
healthy individual (AR) with allogeneic uveal melanoma, protoplasts (P), keyhold limpet haemocyanin (KLH) and schistosome
whole adult worm antigen (S). The results are obtained and displayed as in Figure 1. Positive reactivity was seen with all three
antigens.
haemocyanin and adult schistosome whole worm antigen.
Positive reactivity was seen with all 3 antigens.
Discussion
Patients with uveal melanoma showed equal B-lymphocyte
reactivity with autologous tumour cells and autologous
lymphocytes. This suggested that the recognised antigens
were not necessarily melanoma-associated. Other studies
have apparently shown that patients with uveal melanoma
and other types of malignancy have serum antibodies which
are reactive with normal intracellular proteins (Malaty et al.,
1979).
The reactivity of the peripheral blood B-lymphocytes of
healthy individuals with melanoma cells was very variable
and similar to the allogeneic reactivity seen in patients with
uveal melanoma. It is known that antibodies reactive with
tumour-associated and normal tissue antigens occur in
healthy individuals (Houghton et al., 1980). Furthermore,
monoclonal antibodies reactive with tumours and established
autoantigens have previously been generated from unimmu-
nised human individuals (Shoenfeld & Witz, 1986; Winger et
al., 1983). Such findings have given rise to speculation that
these autoantibodies play a role in the regulation of the
idiotypic network of both B- and T-lymphocytes (Schoenfeld
& Witz, 1986).
Although the measurement of B-lymphocyte reactivity
with melanoma cells from any individual tumour showed
good to moderate reproducability, inconsistent results were
obtained when the ELISA was simultaneously performed
with different uveal melanomas. A similar observation was
made previously (Damato et al., 1986) and is likely to be due
to inter-tumour antigenic heterogeneity, which is a well
recognised phenomenon (Miller, 1982; Natali et al., 1983;
Heppner, 1984; Edwards, 1985).
The finding that B-lymphocyte-derived antibodies also
reacted significantly with foreign antigens that were unlikely
to have been encountered previously is not consistent with
the hypothesis that auto-antibodies play useful roles in vivo.
It may be argued that such results are an artefact of the
ELISA, but such antibodies have been shown to react with
intracellular material by other assays, such as immuno-
fluorescence microscopy (Cote et al., 1983) and immuno-
blotting (Cote et al., 1986).
A possible explanation for the results of this study is that
the antigens are wrongly identified by the antibodies that are
secreted by the transformed B-lymphocytes. In human hybri-
doma technology, whether or not EBV transformation is
employed, the great majority of immortalised lymphocytes
secrete antibody of the IgM isotype (Steel et al., 1977; Chan
et al., 1986; Cote et al., 1986). This antibody, being multiva-
lent, can react spuriously with various antigens in a 'multi-
specific' fashion because any low affinity interactions with
such antigens will be amplified by local concentration effects
(Ghosh & Campbell, 1986; Campbell et al., 1987). The
probability of this irrelevant type of non-specific reaction is
increased when antigens have high epitope densities with a
repeating structure offering a wide variety of regularly
spaced epitopes. Such antigens include single stranded DNA,
actin, myosin and vimentin (Ghosh & Campbell, 1986).
Multispecific antigen-antibody reactions, such as those
seen in the present study, could account for the findings of
previous investigations into the immunology of uveal mela-
noma. Serum IgM antibodies apparently reactive with intra-
cellular proteins, such as actin, for example (Malaty ei al.,
1979), could be directed against totally irrelevant antigens,
such as bacterial and viral antigens. It is also conceivable
that multispecific reactions with abundant cytoplasmic pro-
teins have masked the presence of any antibodies directed
against melanoma-associated membrane antigens. These con-
siderations are also relevant in the production of rodent and
human monoclonal antibodies to melanoma in that the
apparent lack of specificity of an antibody could be due to
multispecific reactivity rather than the expression of the
target antigen in irrelevant cells.
Until such factors are taken into account, possibly by
focusing attention on IgG antibodies reacting with auto-
logous living cells, the existence of an in vivo humoral
immune response to uveal melanoma will remain unproven.
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